| Business Summary | | Rad
Source
Technologies
is
in
the
business
of
researching,
developing
and
producing
commercially
viable
products
that
utilize
x-ray
technology
to
satisfy
various
application
requirements
across
various
industries.
The
Company's
historical
efforts
have
been
in
the
area
of
developing
equipment
which
can
be
substituted
for
that
which
utilizes
radioactive
isotopes
to
produce
radiation.
Rad
Source
has
developed
and
currently
sells
certain
equipment
that
produces
radiation
utilizing
x-rays,
thereby
eliminating
the
need
for
radioactive
sources.
The
Company
has
produced
two
commercially
available
products,
the
RS
3000
Blood
Irradiator
and
the
RS
2000
Biological
Irradiator.
These
products
utilize
x-rays
to
produce
radiation. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | IRAD's
primary
business
is
to
develop,
patent,
manufacture,
market,
and
sell
a
new
irradiation
concept
for
food
and
commercial
irradiation.
For
the
nine
months
ended
6/30/01,
revenues
totalled
$1.3
million,
up
from
$448
thousand.
Net
loss
decreased
90%
to
$17
thousand.
Revenues
reflect
an
increase
in
the
number
of
units
delivered.
Lower
loss
was
partially
offset
by
costs
related
to
unit
sales
and
increased
payroll
costs
from
additional
employees
to
support
growth. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Randol Kirk, 52 Pres,
CEO, Director | $105K | William Hartman, 40 CFO,
Exec. VP, Director | -- | Glenn Thomas VP-Operations | -- | Robert Munson, 58 Other | -- | Dollar
amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|